Approval for device modifications to incorporate identical battery chemistry and implant tester configuration as approved in the spf-xl iib device.  The device, as modified, will be marketed under the trade name spf-plus 60/w and spf-plus 60/m and is indicated as a spinal fusion adjunct to increase the probability of fusion success in 1 or 2 levels.